VITAGRAFT DECENTRALIZED TRANSPLANT MONITORING
Live / Allowed — First extension granted (statement of use) (as of 24 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98766922
- Mark type
- Design + words
- Filed
- 24 Sept 2024
- Published for opposition
- 28 Oct 2025
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in transplantation monitoring and transplantation therapy evaluation.
- Class 044 — Medical, beauty and agricultural services: Medical testing for transplantation monitoring and transplantation therapy evaluation.
Owner
- Oncocyte Corporation, Irvine, CA, US
- Oncocyte Corporation, Irvine, CA, US
Prosecution history
- 24 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2026 — SOU EXTENSION 1 GRANTED
- 23 Jun 2026 — SOU EXTENSION 1 FILED
- 23 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Oct 2025 — PUBLISHED FOR OPPOSITION
- 22 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 27 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 31 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION WRITTEN
- 31 Mar 2025 — ASSIGNED TO EXAMINER
- 30 Mar 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED